Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Ashcroft

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Public Health|July 11, 2006
Reducing variation in antibacterial prescribing rates for 'cough/cold' and sore throat between 1993 and 2001: regional analyses using the general practice research databaseS Smith, G E Smith, H Heatlie, et al.
Rheumatology (Oxford, England)|April 18, 2008
Costing juvenile idiopathic arthritis: examining patient-based costs during the first year after diagnosisJ Thornton, M Lunt, D M Ashcroft, et al.
The British Journal of Dermatology|November 16, 2018
Development and validation of a multivariable risk prediction model for serious infection in patients with psoriasis receiving systemic therapyZ Z N Yiu, C Sorbe, M Lunt, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 26, 2019
Incidence and prevalence of psoriasis in Israel between 2011 and 2017Y Schonmann, D M Ashcroft, I Y K Iskandar, et al.
The British Journal of Dermatology|September 3, 2016
Patterns of biologic therapy use in the management of psoriasis: cohort study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)I Y K Iskandar, D M Ashcroft, R B Warren, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 24, 2019
Assessing the severity of Type 2 diabetes using clinical data-based measures: a systematic reviewS S Zghebi, M Panagioti, M K Rutter, et al.
The British Journal of Dermatology|August 3, 2018
Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the U.K. and Republic of Ireland: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR)Z Z N Yiu, D M Ashcroft, I Evans, et al.
The British Journal of Dermatology|January 11, 2019
Persistence and effectiveness of nonbiologic systemic therapies for moderate-to-severe psoriasis in adults: a systematic reviewK J Mason, S Williams, Z Z N Yiu, et al.
The British Journal of Dermatology|May 20, 2015
Demographics and disease characteristics of patients with psoriasis enrolled in the British Association of Dermatologists Biologic Interventions RegisterI Y K Iskandar, D M Ashcroft, R B Warren, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Public Health|July 11, 2006
Reducing variation in antibacterial prescribing rates for 'cough/cold' and sore throat between 1993 and 2001: regional analyses using the general practice research databaseS Smith, G E Smith, H Heatlie, et al.
Rheumatology (Oxford, England)|April 18, 2008
Costing juvenile idiopathic arthritis: examining patient-based costs during the first year after diagnosisJ Thornton, M Lunt, D M Ashcroft, et al.
The British Journal of Dermatology|November 16, 2018
Development and validation of a multivariable risk prediction model for serious infection in patients with psoriasis receiving systemic therapyZ Z N Yiu, C Sorbe, M Lunt, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 26, 2019
Incidence and prevalence of psoriasis in Israel between 2011 and 2017Y Schonmann, D M Ashcroft, I Y K Iskandar, et al.
The British Journal of Dermatology|September 3, 2016
Patterns of biologic therapy use in the management of psoriasis: cohort study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)I Y K Iskandar, D M Ashcroft, R B Warren, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 24, 2019
Assessing the severity of Type 2 diabetes using clinical data-based measures: a systematic reviewS S Zghebi, M Panagioti, M K Rutter, et al.
The British Journal of Dermatology|August 3, 2018
Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the U.K. and Republic of Ireland: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR)Z Z N Yiu, D M Ashcroft, I Evans, et al.
The British Journal of Dermatology|January 11, 2019
Persistence and effectiveness of nonbiologic systemic therapies for moderate-to-severe psoriasis in adults: a systematic reviewK J Mason, S Williams, Z Z N Yiu, et al.
The British Journal of Dermatology|May 20, 2015
Demographics and disease characteristics of patients with psoriasis enrolled in the British Association of Dermatologists Biologic Interventions RegisterI Y K Iskandar, D M Ashcroft, R B Warren, et al.
Pageof 5